dc.creator |
US National Cancer Institute |
|
dc.date |
2005-08-22T14:54:25Z |
|
dc.date |
2005-08-22T14:54:25Z |
|
dc.date |
2003-02-01 |
|
dc.date |
2005-08-22T14:54:25Z |
|
dc.date.accessioned |
2022-05-25T06:42:26Z |
|
dc.date.available |
2022-05-25T06:42:26Z |
|
dc.identifier |
NSC51812 |
|
dc.identifier |
http://www.dspace.cam.ac.uk/handle/1810/50991 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/162928 |
|
dc.format |
8610 bytes |
|
dc.format |
7426 bytes |
|
dc.format |
chemical/x-cml |
|
dc.format |
chemical/x-cml |
|
dc.language |
en_GB |
|
dc.publisher |
Unilever Center for Molecular Informatics, Cambridge University |
|
dc.title |
NSC51812 |
|
dc.title |
Bonomycin hydrochloride |
|
dc.title |
BONOMYCIN |
|
dc.title |
FDA 0129 |
|
dc.title |
GS 2147 |
|
dc.title |
Sancycline (USAN) |
|
dc.title |
Sancycline hydrochloride |
|
dc.title |
SANCYCLINE |
|
dc.title |
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11, 12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5a.alpha., 12a.alpha.)]- (9CI) |
|
dc.title |
2-Naphthacenecarboxamide, 4-dimethylamino-1, 4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride |
|
dc.type |
Chemical Structures |
|